Oral Glucose Tolerance Testing After Gestational Diabetes
1 other identifier
observational
118
1 country
2
Brief Summary
This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2012
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 6, 2014
CompletedFirst Posted
Study publicly available on registry
March 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFebruary 25, 2020
February 1, 2020
3.6 years
March 6, 2014
February 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcome: sensitivity of immediate post partum screen
2 hour fasting 75g OGTT immediately post partum. This is compared to a traditional 6 week post partum 75g OGTT for the sensitivity, positive and negative predictive value of the immediate post partum test
Immediate post partum
Secondary Outcomes (1)
Secondary outcome: physiology
3 time points: antepatum, immediate postpartum, 6 weeks post partum
Study Arms (1)
Gestational diabetes
Primary cohort is women with diagnosis of gestational diabetes without evidence of overt diabetes
Eligibility Criteria
Primary cohort is obtained from a pregnant population at two academic medical centers.
You may qualify if:
- Singleton pregnancy
- Gestational diabetes
You may not qualify if:
- Multiple gestations
- pre-pregnancy diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MetroHealth Medical Centerlead
- Centers for Disease Control and Preventioncollaborator
- Loyola Universitycollaborator
Study Sites (2)
University Hospital
Cleveland, Ohio, 44106, United States
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
Related Publications (1)
Waters TP, Kim SY, Sharma AJ, Schnellinger P, Bobo JK, Woodruff RT, Cubbins LA, Haghiac M, Minium J, Presley L, Wolfe H, Hauguel-de Mouzon S, Adams W, Catalano PM. Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period. Diabetologia. 2020 Feb;63(2):385-394. doi: 10.1007/s00125-019-05051-0. Epub 2019 Dec 9.
PMID: 31820038DERIVED
Biospecimen
Serum for measurements of insulin, markers of inflammation
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thaddeus Waters, MD
Loyola University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 6, 2014
First Posted
March 10, 2014
Study Start
October 1, 2012
Primary Completion
May 4, 2016
Study Completion
December 31, 2019
Last Updated
February 25, 2020
Record last verified: 2020-02